SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aurobindo Pharma to expand footprint in Europe: Report

22 Feb 2016 Evaluate

Aurobindo Pharma is reportedly planning to expand its footprint in newer markets in the European Union. The Hyderabad-based company intends to consolidate its position and presence among the top 10 companies in Europe.

The proposed expansion will not just be in new markets such as Poland and Czech Republic, but there will also be portfolio expansion through targeted first day launches in orals, hormonals, penems, oncology drugs and niche injectables, among others, according to the information shared in its latest investor presentation.

Aurobindo Pharma Share Price

1560.05 7.25 (0.47%)
02-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1871.55
Dr. Reddys Labs. 1346.25
Cipla 1456.25
Zydus Lifesciences 1099.65
Lupin 2398.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: